Envestnet Asset Management Inc. Sells 2,317 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)

Envestnet Asset Management Inc. cut its stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 1.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 131,662 shares of the biopharmaceutical company’s stock after selling 2,317 shares during the period. Envestnet Asset […]